查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566005

蛋白质结合检测市场 - 全球规模、份额、趋势分析、机会、预测，2019-2030 年

Protein Binding Assays Market, By Technology; By Products & Services; By End User; By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa ), Global Trend Analysis, Competitive Landscape & Forecast, 2019-2030
出版日期: | 出版商: Blueweave Consulting | 英文 400 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球蛋白质结合检测市场将以约 10% 的复合年增长率扩大，到 2030 年将超过 8.53 亿美元

由于药物发现和药物开发活动的活性化、慢性病的增加、药物研发投资的增加以及结合技术和方法的进步，全球蛋白质结合测定市场正在蓬勃发展。

领先的策略咨询和市场研究公司 BlueWeave Consulting 在最近的一项研究中以金额为准，2023 年全球蛋白结合检测市场规模为 4.4452 亿美元。 BlueWeave 预测，在 2024 年至 2030 年的预测期内，全球蛋白质结合检测市场规模将以 9.77% 的复合年增长率成长，到 2030 年将达到 8.5353 亿美元。蛋白质结合检测的全球市场由几个关键因素推动，包括药物发现的进步、对蛋白质-蛋白质相互作用的了解的加深以及对个人化医疗的需求不断增加。此外，高通量筛检和萤光检测的技术进步正在提高这些检测的效率和准确性。製药和生物技术行业的崛起以及药物开发的不断努力进一步推动了全球蛋白质结合检测市场的成长。

机会 - 扩展到伴同性诊断

伴同性诊断的日益普及预计将在分析期间促进全球蛋白质结合分析市场的复合年增长率的成长。随着个人化医疗的发展，伴同性诊断越来越多地被用来预测患者对特定治疗的反应。这种扩展需要准确的蛋白质结合测定来评估药物-蛋白质交互作用，这对于确定药物功效和安全性非常重要。将这些检测方法整合到伴同性诊断中正在增加它们在药物开发中的相关性并推动市场开拓。

地缘政治紧张局势加剧对全球蛋白质结合检测市场的影响

地缘政治紧张局势的加剧可能会影响供应链、增加原材料成本并导致生产和分销延迟，从而扰乱全球蛋白质结合检测市场。贸易限制和製裁可能会限制关键成分的获取，而市场不确定性可能会减少研发投资。此外，地缘政治的不稳定性可能会将市场重点转向国内采购，从而影响区域市场动态并减缓产业对新技术的采用。

生物製药公司在最终用户中占有最大份额

製药和生物技术公司是全球蛋白质结合测定市场最大的最终用户。由于对药物发现和市场开发过程的高需求（蛋白质结合测量在其中发挥关键作用），生物製药公司占据了市场主导地位。对个人化医疗的日益关注以及全球製药和生物技术公司的激增对该行业的市场主导地位做出了重大贡献。全球蛋白质结合检测市场的其他主要最终用户包括 CRO 和顾问公司。

竞争格局

全球蛋白质结合检测市场竞争激烈，许多公司竞相扩大市场占有率。市场的主要企业包括 Thermo Fisher Scientific, Inc.、Charles River、Sovicell GMBH、XenoTech、GE Healthcare、Eurofins Scientific、Creative Biolabs、Evotec (Cyprotex)、Bioduro、BioAgilytix Labs、WuXi AppTec 和 Domainex。这些公司正在利用各种策略，例如增加研发活动投资、併购、合资、联盟、许可协议以及新产品和服务发布，以进一步巩固自己在全球蛋白质结合测定市场的地位。

该报告的详细分析提供了有关全球蛋白质结合测定市场的成长潜力、未来趋势和统计数据的资讯。我们也研究了推动市场总规模预测的因素。该报告致力于提供全球蛋白质结合测定市场的最新技术趋势和产业见解，以帮助决策者做出明智的策略决策。此外，我们也分析了市场的成长动力、挑战和竞争力。

目录

第一章 研究框架

第 2 章执行摘要

第三章全球蛋白质结合分析市场洞察

  • 产业价值链分析
  • DROC分析
    • 生长促进因子
      • 增加药物发现和开发活动
      • 慢性病流行
      • 个人化医疗日益受到关注
    • 抑制因素
      • 与检测开发和检验相关的高成本
      • 蛋白质-药物交互作用的复杂性
      • 耗时的分析步骤
    • 机会
      • 生物相似药和生技改良药的开发
      • 扩展到伴同性诊断
      • 开发新的检测平台
    • 任务
      • 分析技术和方法的保护
      • 从蛋白质结合资料中提取有意义的见解
      • 标准化通讯协定的可用性有限
  • 科技进步/最新趋势
  • 法律规范
  • 波特五力分析

第四章全球蛋白质结合测定市场：行销策略

第五章全球蛋白质结合检测市场：价格分析

第六章全球蛋白质结合分析市场：区域分析

  • 全球蛋白质结合检测市场，区域分析，2023 年
  • 全球蛋白质结合分析市场，吸引力分析，2024-2030

第七章全球蛋白质结合测定市场概述

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 依技术
      • 平衡透析
      • 亲和电泳
      • 超过滤
      • 超速离心
      • 表面等离子体共振
      • 其他的
    • 按产品和服务
      • 装置
      • 试剂套件和试剂
      • 服务
    • 按最终用户
      • 製药和生物技术公司
      • CRO
      • 顾问公司
      • 其他的
    • 按地区
      • 北美洲
      • 欧洲
      • 亚太地区 (APAC)
      • 拉丁美洲 (LATAM)
      • 中东和非洲（中东/非洲）

第八章北美蛋白质结合检测市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 依技术
    • 按产品/服务
    • 按最终用户
    • 按国家/地区
      • 美国
      • 加拿大

第九章欧洲蛋白质结合检测市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 依技术
    • 按产品/服务
    • 按最终用户
    • 按国家/地区
      • 德国
      • 英国
      • 义大利
      • 法国
      • 西班牙
      • 比利时
      • 俄罗斯
      • 荷兰
      • 其他欧洲国家

第10章亚太地区蛋白质结合分析市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 依技术
    • 按产品/服务
    • 按最终用户
    • 按国家/地区
      • 中国
      • 印度
      • 日本
      • 韩国
      • 澳洲和纽西兰
      • 印尼
      • 马来西亚
      • 新加坡
      • 越南
      • 亚太地区其他国家

第十一章拉丁美洲蛋白质结合检测市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 依技术
    • 按产品/服务
    • 按最终用户
    • 按国家/地区
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘鲁
      • 其他拉丁美洲

第十二章中东和非洲蛋白质结合检测市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 依技术
    • 按产品/服务
    • 按最终用户
    • 按国家/地区
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 卡达
      • 科威特
      • 南非
      • 奈及利亚
      • 阿尔及利亚
      • 中东和非洲其他地区

第十三章竞争格局

  • 主要企业及其产品列表
  • 2023年全球蛋白质结合检测公司市场占有率分析
  • 透过管理参数进行竞争基准基准化分析
  • 主要策略发展（合併、收购、联盟）

第14章地缘政治紧张局势加剧对全球蛋白质结合检测市场的影响

第十五章 公司简介（公司简介、财务矩阵、竞争格局、关键人员、主要竞争对手、联络方式、策略展望、SWOT分析）

  • Thermo Fisher Scientific, Inc.
  • Charles River
  • Sovicell GMBH
  • XenoTech
  • GE Healthcare
  • Eurofins Scientific
  • Creative Biolabs
  • Evotec（Cyprotex）
  • Bioduro
  • BioAgilytix Labs
  • WuXi AppTec
  • Domainex
  • 其他主要企业

第十六章 主要策略建议

第十七章调查方法

简介目录
Product Code: BWC24635

Global Protein Binding Assays Market Expands at CAGR of almost 10% to Surpass Value of USD 853 Million by 2030

Global Protein Binding Assays Market is thriving due to rising drug discovery and development activities, increasing prevalence of chronic diseases, growing pharmaceutical R&D investments, and advancements in binding technologies and techniques.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated Global Protein Binding Assays Market size by value at USD 444.52 million in 2023. During the forecast period between 2024 and 2030, BlueWeave expects Global Protein Binding Assays Market size to expand at a CAGR of 9.77% reaching a value of USD 853.53 million in 2030. Global Protein Binding Assays Market is driven by several key factors including advancements in drug discovery, a growing understanding of protein-protein interactions, and the increasing demand for personalized medicine. Additionally, technological advancements in high-throughput screening and fluorescence-based assays enhance the efficiency and accuracy of these assays. The rising pharmaceutical and biotechnology industries, along with continuous efforts in drug development, further propel the growth of Global Protein Binding Assays Market.

Opportunity - Expansion into Companion Diagnostics

The growing adoption of companion diagnostics is expected to boost the growth of Global Protein Binding Assays Market at a significant CAGR during the period in analysis. As personalized medicine gains momentum, companion diagnostics are increasingly used to predict patient response to specific therapies. The expansion requires accurate protein binding assays to assess drug-protein interactions, which are critical in determining drug efficacy and safety. The integration of these assays into companion diagnostics enhances their relevance in drug development, driving market growth.

Impact of Escalating Geopolitical Tensions on Global Protein Binding Assays Market

Escalating geopolitical tensions can disrupt the Global Protein Binding Assays Market by affecting supply chains, increasing costs of raw materials, and causing delays in production and distribution. Trade restrictions and sanctions may limit access to critical components, while market uncertainty could lead to reduced investment in research and development. Additionally, geopolitical instability may shift market focus toward domestic sourcing, influencing regional market dynamics and potentially slowing the adoption of new technologies in the industry.

Biopharma Companies Hold Largest Share in Market by End User

The pharmaceutical and biotechnology companies segment is the largest end user segment in Global Protein Binding Assays Market. Biopharma companies dominate the market due to the high demand for drug discovery and development processes, where protein binding assays play a critical role. The increasing focus on personalized medicine and the growing number of pharmaceutical and biotech firms globally contribute significantly to the segment's dominance in the market. The other major end user segments in Global Protein Binding Assays Market include CROs and consulting firms.

Competitive Landscape

Global Protein Binding Assays Market is fiercely competitive, with numerous companies vying for a larger market share. Major companies in the market include Thermo Fisher Scientific, Inc., Charles River, Sovicell GMBH, XenoTech, GE Healthcare, Eurofins Scientific, Creative Biolabs, Evotec (Cyprotex), Bioduro, BioAgilytix Labs, WuXi AppTec, and Domainex. These companies use various strategies, including increasing investments in their R&D activities, mergers and acquisitions, joint ventures, collaborations, licensing agreements, and new product and service releases to further strengthen their position in Global Protein Binding Assays Market.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Protein Binding Assays Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Protein Binding Assays Market and industry insights to help decision-makers make sound strategic decisions. Further, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Protein Binding Assays Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Increasing drug discovery and development activities
      • 3.2.1.2. Rising prevalence of chronic diseases
      • 3.2.1.3. Growing emphasis on personalized medicine
    • 3.2.2. Restraints
      • 3.2.2.1. High costs associated with assay development and validation
      • 3.2.2.2. Complex nature of protein-drug interactions
      • 3.2.2.3. Time-consuming assay procedures
    • 3.2.3. Opportunities
      • 3.2.3.1. Development of biosimilars and bio betters
      • 3.2.3.2. Expansion into companion diagnostics
      • 3.2.3.3. Development of novel assay platforms
    • 3.2.4. Challenges
      • 3.2.4.1. Protecting assay technologies and methods
      • 3.2.4.2. Extracting meaningful insights from protein binding data
      • 3.2.4.3. Limited availability of standardized protocols
  • 3.3. Technological Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Protein Binding Assays Market: Marketing Strategies

5. Global Protein Binding Assays Market: Pricing Analysis

6. Global Protein Binding Assays Market: Geography Analysis

  • 6.1. Global Protein Binding Assays Market, Geographical Analysis, 2023
  • 6.2. Global Protein Binding Assays, Market Attractiveness Analysis, 2024-2030

7. Global Protein Binding Assays Market Overview

  • 7.1. Market Size & Forecast, 2019-2030
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technology
      • 7.2.1.1. Equilibrium Dialysis
      • 7.2.1.2. Affinity Electrophoresis
      • 7.2.1.3. Ultrafiltration
      • 7.2.1.4. Ultracentrifugation
      • 7.2.1.5. Surface Plasmon Resonance
      • 7.2.1.6. Others
    • 7.2.2. By Products and Services
      • 7.2.2.1. Instruments
      • 7.2.2.2. Kits & Reagents
      • 7.2.2.3. Services
    • 7.2.3. By End User
      • 7.2.3.1. Pharmaceutical & Biotechnology Companies
      • 7.2.3.2. CROs
      • 7.2.3.3. Consulting Firms
      • 7.2.3.4. Others
    • 7.2.4. By Region
      • 7.2.4.1. North America
      • 7.2.4.2. Europe
      • 7.2.4.3. Asia Pacific (APAC)
      • 7.2.4.4. Latin America (LATAM)
      • 7.2.4.5. Middle East and Africa (MEA)

8. North America Protein Binding Assays Market

  • 8.1. Market Size & Forecast, 2019-2030
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technology
    • 8.2.2. By Product and Services
    • 8.2.3. By End User
    • 8.2.4. By Country
      • 8.2.4.1. United States
      • 8.2.4.1.1. By Technology
      • 8.2.4.1.2. By Product and Services
      • 8.2.4.1.3. By End User
      • 8.2.4.2. Canada
      • 8.2.4.2.1. By Technology
      • 8.2.4.2.2. By Product and Services
      • 8.2.4.2.3. By End User

9. Europe Protein Binding Assays Market

  • 9.1. Market Size & Forecast, 2019-2030
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technology
    • 9.2.2. By Product and Services
    • 9.2.3. By End User
    • 9.2.4. By Country
      • 9.2.4.1. Germany
      • 9.2.4.1.1. By Technology
      • 9.2.4.1.2. By Product and Services
      • 9.2.4.1.3. By End User
      • 9.2.4.2. United Kingdom
      • 9.2.4.2.1. By Technology
      • 9.2.4.2.2. By Product and Services
      • 9.2.4.2.3. By End User
      • 9.2.4.3. Italy
      • 9.2.4.3.1. By Technology
      • 9.2.4.3.2. By Product and Services
      • 9.2.4.3.3. By End User
      • 9.2.4.4. France
      • 9.2.4.4.1. By Technology
      • 9.2.4.4.2. By Product and Services
      • 9.2.4.4.3. By End User
      • 9.2.4.5. Spain
      • 9.2.4.5.1. By Technology
      • 9.2.4.5.2. By Product and Services
      • 9.2.4.5.3. By End User
      • 9.2.4.6. Belgium
      • 9.2.4.6.1. By Technology
      • 9.2.4.6.2. By Product and Services
      • 9.2.4.6.3. By End User
      • 9.2.4.7. Russia
      • 9.2.4.7.1. By Technology
      • 9.2.4.7.2. By Product and Services
      • 9.2.4.7.3. By End User
      • 9.2.4.8. The Netherlands
      • 9.2.4.8.1. By Technology
      • 9.2.4.8.2. By Product and Services
      • 9.2.4.8.3. By End User
      • 9.2.4.9. Rest of Europe
      • 9.2.4.9.1. By Technology
      • 9.2.4.9.2. By Product and Services
      • 9.2.4.9.3. By End User

10. Asia Pacific Protein Binding Assays Market

  • 10.1. Market Size & Forecast, 2019-2030
    • 10.1.1. By Value (USD Million)
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technology
    • 10.2.2. By Product and Services
    • 10.2.3. By End User
    • 10.2.4. By Country
      • 10.2.4.1. China
      • 10.2.4.1.1. By Technology
      • 10.2.4.1.2. By Product and Services
      • 10.2.4.1.3. By End User
      • 10.2.4.2. India
      • 10.2.4.2.1. By Technology
      • 10.2.4.2.2. By Product and Services
      • 10.2.4.2.3. By End User
      • 10.2.4.3. Japan
      • 10.2.4.3.1. By Technology
      • 10.2.4.3.2. By Product and Services
      • 10.2.4.3.3. By End User
      • 10.2.4.4. South Korea
      • 10.2.4.4.1. By Technology
      • 10.2.4.4.2. By Product and Services
      • 10.2.4.4.3. By End User
      • 10.2.4.5. Australia & New Zealand
      • 10.2.4.5.1. By Technology
      • 10.2.4.5.2. By Product and Services
      • 10.2.4.5.3. By End User
      • 10.2.4.6. Indonesia
      • 10.2.4.6.1. By Technology
      • 10.2.4.6.2. By Product and Services
      • 10.2.4.6.3. By End User
      • 10.2.4.7. Malaysia
      • 10.2.4.7.1. By Technology
      • 10.2.4.7.2. By Product and Services
      • 10.2.4.7.3. By End User
      • 10.2.4.8. Singapore
      • 10.2.4.8.1. By Technology
      • 10.2.4.8.2. By Product and Services
      • 10.2.4.8.3. By End User
      • 10.2.4.9. Vietnam
      • 10.2.4.9.1. By Technology
      • 10.2.4.9.2. By Product and Services
      • 10.2.4.9.3. By End User
      • 10.2.4.10. Rest of APAC
      • 10.2.4.10.1. By Technology
      • 10.2.4.10.2. By Product and Services
      • 10.2.4.10.3. By End User

11. Latin America Protein Binding Assays Market

  • 11.1. Market Size & Forecast, 2019-2030
    • 11.1.1. By Value (USD Million)
  • 11.2. Market Share & Forecast
    • 11.2.1. By Technology
    • 11.2.2. By Product and Services
    • 11.2.3. By End User
    • 11.2.4. By Country
      • 11.2.4.1. Brazil
      • 11.2.4.1.1. By Technology
      • 11.2.4.1.2. By Product and Services
      • 11.2.4.1.3. By End User
      • 11.2.4.2. Mexico
      • 11.2.4.2.1. By Technology
      • 11.2.4.2.2. By Product and Services
      • 11.2.4.2.3. By End User
      • 11.2.4.3. Argentina
      • 11.2.4.3.1. By Technology
      • 11.2.4.3.2. By Product and Services
      • 11.2.4.3.3. By End User
      • 11.2.4.4. Peru
      • 11.2.4.4.1. By Technology
      • 11.2.4.4.2. By Product and Services
      • 11.2.4.4.3. By End User
      • 11.2.4.5. Rest of LATAM
      • 11.2.4.5.1. By Technology
      • 11.2.4.5.2. By Product and Services
      • 11.2.4.5.3. By End User

12. Middle East & Africa Protein Binding Assays Market

  • 12.1. Market Size & Forecast, 2019-2030
    • 12.1.1. By Value (USD Million)
  • 12.2. Market Share & Forecast
    • 12.2.1. By Technology
    • 12.2.2. By Product and Services
    • 12.2.3. By End User
    • 12.2.4. By Country
      • 12.2.4.1. Saudi Arabia
      • 12.2.4.1.1. By Technology
      • 12.2.4.1.2. By Product and Services
      • 12.2.4.1.3. By End User
      • 12.2.4.2. UAE
      • 12.2.4.2.1. By Technology
      • 12.2.4.2.2. By Product and Services
      • 12.2.4.2.3. By End User
      • 12.2.4.3. Qatar
      • 12.2.4.3.1. By Technology
      • 12.2.4.3.2. By Product and Services
      • 12.2.4.3.3. By End User
      • 12.2.4.4. Kuwait
      • 12.2.4.4.1. By Technology
      • 12.2.4.4.2. By Product and Services
      • 12.2.4.4.3. By End User
      • 12.2.4.5. South Africa
      • 12.2.4.5.1. By Technology
      • 12.2.4.5.2. By Product and Services
      • 12.2.4.5.3. By End User
      • 12.2.4.6. Nigeria
      • 12.2.4.6.1. By Technology
      • 12.2.4.6.2. By Product and Services
      • 12.2.4.6.3. By End User
      • 12.2.4.7. Algeria
      • 12.2.4.7.1. By Technology
      • 12.2.4.7.2. By Product and Services
      • 12.2.4.7.3. By End User
      • 12.2.4.8. Rest of MEA
      • 12.2.4.8.1. By Technology
      • 12.2.4.8.2. By Product and Services
      • 12.2.4.8.3. By End User

13. Competitive Landscape

  • 13.1. List of Key Players and Their Offerings
  • 13.2. Global Protein Binding Assays Company Market Share Analysis, 2023
  • 13.3. Competitive Benchmarking, By Operating Parameters
  • 13.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships)

14. Impact of Escalating Geopolitical Tensions on Global Protein Binding Assays Market

15. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)

  • 15.1. Thermo Fisher Scientific, Inc.
  • 15.2. Charles River
  • 15.3. Sovicell GMBH
  • 15.4. XenoTech
  • 15.5. GE Healthcare
  • 15.6. Eurofins Scientific
  • 15.7. Creative Biolabs
  • 15.8. Evotec (Cyprotex)
  • 15.9. Bioduro
  • 15.10. BioAgilytix Labs
  • 15.11. WuXi AppTec
  • 15.12. Domainex
  • 15.13. Other Prominent Players

16. Key Strategic Recommendations

17. Research Methodology

  • 17.1. Qualitative Research
    • 17.1.1. Primary & Secondary Research
  • 17.2. Quantitative Research
  • 17.3. Market Breakdown & Data Triangulation
    • 17.3.1. Secondary Research
    • 17.3.2. Primary Research
  • 17.4. Breakdown of Primary Research Respondents, By Region
  • 17.5. Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable